UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 8, 2015
STEREOTAXIS, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction
of Incorporation)
001-36159 | 94-3120386 | |
(Commission File Number) |
(IRS Employer Identification No.) | |
4320 Forest Park Avenue, Suite 100, St. Louis, Missouri | 63108 | |
(Address of Principal Executive Offices) | (Zip Code) |
(314) 678-6100
(Registrants Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. | Other Events. |
On October 8, 2015, Stereotaxis, Inc. issued a press release announcing the results of its previously announced warrants offering. A copy of this press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
99.1 | Stereotaxis, Inc. Press Release dated October 8, 2015 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
STEREOTAXIS, INC. | ||||||
Date: October 8, 2015 | By: | /s/ Karen Witte Duros | ||||
Name: | Karen Witte Duros | |||||
Title: | Sr. Vice President, General Counsel |
Exhibit 99.1
Stereotaxis Announces Results of Warrants Offering
ST. LOUIS, MO, October 8, 2015 Stereotaxis, Inc. (Stereotaxis) (NASDAQ: STXS) a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of its previously announced offering of subscription warrants to purchase shares of its common stock at a price of $1.10 per share. Pursuant to the warrants offering, subscription warrants to purchase approximately 0.3 million shares of common stock were exercised, resulting in gross proceeds to Stereotaxis of approximately $300,000.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities.
About Stereotaxis
Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis core Epoch® Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive robotic navigation system and consumables.
The core components of Stereotaxis systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. The V-Sono ICE catheter manipulator, V-Loop variable loop catheter manipulator, and V-CAS catheter advancement system have received clearance in the United States, Canada, and the European Union. For more information, please visit www.stereotaxis.com.
STXS Company Contact: | STXS Investor Contact: | |||
Martin Stammer | Todd Kehrli / Jim Byers | |||
Chief Financial Officer | MKR Group, Inc. | |||
314-678-6155 | 323-468-2300 | |||
stxs@mkr-group.com |